EnteroBiotix appoints COO and CFO

EnteroBiotix Ltd
Appointee name
James Barnes and Chris Lea

United Kingdom

EnteroBiotix Ltd, which has developed a platform for full-spectrum gut microbiome therapeutics, has appointed James Barnes as chief operating officer and Chris Lea as chief financial officer. Dr Barnes joins from BerGenBio ASA where he was COO and brings 18 years of experience in early and late phase drug development and business operations. Mr Lea was previously CFO of AIM-listed Cambridge Nutritional Sciences Plc as well as of two other AIM-listed companies, IndigoVision Group Plc and Superglass Holdings Plc. He holds a BSc in Physics from Nottingham University and is a member of the Institute of Chartered Accountants in England and Wales.

EnteroBiotix announced the appointments on 1 February 2024.

Copyright 2024 Evernow Publishing Ltd